Publications

Diagnostic | Clinique – épidémiologie | Physiopathologie | Résistance

Diagnostic

retour en haut

Année 2019

• Kamaliddin C, Joste V, Hubert V, Kendjo E, Argy N, Houze S. Evaluation of PCR To Monitor Plasmodium falciparum Treatment Efficacy in a Nonendemicity Setting. J Clin Microbiol. 2019 Dec 23;58(1).

Année 2018

• Douine M, Sanna A, Galindo M, Musset L, Pommier de Santi V, Marchesini P, et al. Malakit: an innovative pilot project to self-diagnose and self-treat malaria among illegal gold miners in the Guiana Shield. Malar J. 2018 Apr 10;17(1):158.
• Joste V, Kamaliddin C, Kendjo E, Hubert V, Argy N, Houzé S. Distinction of Plasmodium ovale wallikeri and Plasmodium ovale curtisi using quantitative Polymerase Chain Reaction with High Resolution Melting revelation. Scientific Reports. 2018 Jan 10;8(1):1–8.

Année 2017

• Ndour PA, Larréché S, Mouri O, Argy N, Gay F, Roussel C, et al. Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts postartesunate delayed hemolysis. Sci Transl Med. 2017 05;9(397).

Année 2013

• Trouvay M, Palazon G, Berger F, Volney B, Blanchet D, Faway E, et al. High performance of histidine-rich protein 2 based rapid diagnostic tests in French Guiana are explained by the absence of pfhrp2 gene deletion in P. falciparum. PLoS One.  2013;8(9):e74269.
• Houzé S, Boutron I, Marmorat A, Dalichampt M, Choquet C, Poilane I, et al. Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study. PLoS One. 2013;8(9):e75486.

Année 2011

• Houzé S, Hubert V, Le Pessec G, Le Bras J, Clain J. Combined deletions of pfhrp2 and pfhrp3 genes result in Plasmodium falciparum malaria false-negative rapid diagnostic test. J Clin Microbiol. 2011 Jul;49(7):2694–6.
• Houzé S, Hubert V, Cohen DP, Rivetz B, Le Bras J. Evaluation of the Clearview® Malaria pLDH Malaria Rapid Diagnostic Test in a non-endemic setting. Malar J. 2011 Sep 27;10:284.

Année 2009

• Houzé S, Boly MD, Le Bras J, Deloron P, Faucher J-F. PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria. Malar J. 2009 Sep 7;8:211.

Année 2007

• Houzé S, Munier A, Paoletti X, Kaddouri H, Ringwald P, Le Bras J. Shelf life of predosed plates containing mefloquine, artemisinin, dihydroartemisinin, and artesunate as used for in vitro Plasmodium falciparum susceptibility assessment. J Clin Microbiol. 2007 Aug;45(8):2734–6.
• Talman AM, Duval L, Legrand E, Hubert V, Yen S, Bell D, et al. Evaluation of the intra- and inter-specific genetic variability of Plasmodium lactate dehydrogenase. Malar J. 2007 Oct 25;6:140.

Clinique - épidémiologie

retour en haut

Année 2021

• Valentin Joste, Justine Bailly, Véronique Hubert, Cécile Pauc, Mathieu Gendrot, Emilie Guillochon, Marylin Madamet, Marc Thellier, Eric Kendjo, Nicolas Argy, Bruno Pradines, Sandrine Houzé, French National Reference Center for Imported Malaria Study Group1. Plasmodium ovale wallikeri and P. ovale curtisi Infections and Diagnostic Approaches to Imported Malaria, France, 2013-2018

Année 2020

• El Ket N, Kendjo E, Thellier M, Assoumou L, Potard V, Taieb A, et al. Propensity Score Analysis of Artesunate Versus Quinine for Severe Imported Plasmodium falciparum Malaria in France. Clin Infect Dis. 2020 02;70(2):280–7.
• Leblanc C, Vasse C, Minodier P, Mornand P, Naudin J, Quinet B, et al. Management and prevention of imported malaria in children. Update of the French guidelines. Med Mal Infect. 2020 Mar;50(2):127–40.
• Thellier M, Simard F, Musset L, Cot M, Velut G, Kendjo E, et al. Changes in malaria epidemiology in France and worldwide, 2000-2015. Med Mal Infect. 2020 Mar;50(2):99–112.
• Kamaliddin C, Le Bouar M, Berry A, Fenneteau O, Gillet P, Godineau N, et al. Assessment of diagnostic methods for imported malaria in mainland France. Med Mal Infect. 2020;50(2):141–60.
• Mosnier E, Roux E, Cropet C, Lazrek Y, Moriceau O, Gaillet M, et al. Prevalence of Plasmodium spp. in the Amazonian Border Context (French Guiana-Brazil): Associated Factors and Spatial Distribution. Am J Trop Med Hyg. 2020;102(1):130–41.
• Bouchaud O, Bruneel F, Caumes E, Houzé S, Imbert P, Pradines B, et al. Management and prevention of imported malaria. 2018 update of the 2007 French clinical guidelines. Médecine et Maladies Infectieuses. 2020 Mar 1;50(2):161–93.
• Amoura A, Moktefi A, Halfon M, Karras A, Rafat C, Gibier J-B, et al. Malaria, Collapsing Glomerulopathy, and Focal and Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2020 Jul 1;15(7):964–72.
• Kendjo E, Thellier M, Noël H, Jauréguiberry S, Septfons A, Mouri O, et al. Mortality from malaria in France, 2005 to 2014. Euro Surveill. 2020 Sep;25(36).
• Lebut J, Mourvillier B, Argy N, Dupuis C, Vinclair C, Radjou A, et al. Changes in the clinical presentation and outcomes of patients treated for severe malaria in a referral French university intensive care unit from 2004 to 2017. Ann Intensive Care. 2020 Feb 12;10(1):21.

Année 2019

• Kendjo E, Houzé S, Mouri O, Taieb A, Gay F, Jauréguiberry S, et al. Epidemiologic Trends in Malaria Incidence Among Travelers Returning to Metropolitan France, 1996-2016. JAMA Netw Open. 2019 05;2(4):e191691.
• Argemi X, Houze S, Noel H, Broca O, Chidiac C, Rapp C. Imported Plasmodium falciparum malaria following non-pharmaceutical forms of Artemisia annua prophylaxis. J Travel Med. 2019 Dec 23;26(8).
• Izri A, Cojean S, Leblanc C, Cohen Y, Bouchaud O, Durand R. Plasmodium vivax severe imported malaria in two migrants in France. Malar J. 2019 Dec 16;18(1):422.

Année 2018

• Kamaliddin C, Joste V, Argy N, Houzé S. [Fluindione and falciparum malaria treated by atovaquone-proguanil]. Therapie. 2018 Oct;73(5):445–7.
• Malvy D, Torrentino-Madamet M, L’Ollivier C, Receveur M-C, Jeddi F, Delhaes L, et al. Plasmodium falciparum Recrudescence Two Years after Treatment of an Uncomplicated Infection without Return to an Area Where Malaria Is Endemic. Antimicrob Agents
  Chemother. 2018;62(2).

Année 2017

• Douine M, Mosnier E, Le Hingrat Q, Charpentier C, Corlin F, Hureau L, et al. Illegal gold miners in French Guiana: a neglected population with poor health. BMC Public Health. 2017 17;18(1):23.
• Mornand P, Verret C, Minodier P, Faye A, Thellier M, Imbert P, et al. Severe imported malaria in children in France. A national retrospective study from 1996 to 2005. PLoS One. 2017;12(7):e0180758.
• Mosnier E, Douine M, Epelboin L, Pelleau S, Pommier de Santi V, Dangel Y, et al. Asymptomatic Plasmodium falciparum and vivax infection in the neighborhood of Blondin, Saint-Georges-de-l’Oyapock District, French Guiana. Bull Soc Pathol Exot. 2017 Oct;110(4):265–9.
• Siriez J-Y, Prendki V, Dauger S, Michel J-F, Blondé R, Faye A, et al. Post-Malaria Neurologic Syndrome: A Rare Pediatric Case Report. Pediatr Infect Dis J. 2017 Dec;36(12):1217–9.

Année 2016

• Casalino E, Etienne A, Mentré F, Houzé S, Imported Malaria Hospitalization Study Group. Hospitalization and ambulatory care in imported-malaria: evaluation of trends and impact on mortality. A prospective multicentric 14-year observational study. Malar J. 2016 Jun 7;15:312.
• Douine M, Musset L, Corlin F, Pelleau S, Pasquier J, Mutricy L, et al. Prevalence of Plasmodium spp. in illegal gold miners in French Guiana in 2015: a hidden but critical malaria reservoir. Malar J. 2016 09;15:315.

Année 2014

• Jauréguiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M, et al. Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins. Blood. 2014 Jul 10;124(2):167–75.
• Mellon G, Ficko C, Thellier M, Kendjo E, Aoun O, Adriamanantena D, et al. Two cases of late Plasmodium ovale presentation in military personnel. J Travel Med. 2014 Feb;21(1):52–4.

Année 2011

• Seringe E, Thellier M, Fontanet A, Legros F, Bouchaud O, Ancelle T, et al. Severe imported
  Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis. 2011 May;17(5):807–
  13.

Année 2010

• Bellanger A-P, Bruneel F, Barbot O, Mira J-P, Millon L, Houzé P, et al. Severe Plasmodium malariae malaria in a patient with multiple susceptibility genes. J Travel Med. 2010
  Jun;17(3):201–2.
• Bruneel F, Tubach F, Corne P, Megarbane B, Mira J-P, Peytel E, et al. Severe imported
  falciparum malaria: a cohort study in 400 critically ill adults. PLoS One. 2010 Oct
  8;5(10):e13236.

Année 2009

• Descheemaeker P-N, Mira J-P, Bruneel F, Houzé S, Tanguy M, Gangneux J-P, et al. Near-fatal multiple organ dysfunction syndrome induced by Plasmodium malariae. Emerg Infect Dis. 2009 May;15(5):832–4.
• Mouala C, Guiguet M, Houzé S, Damond F, Pialoux G, Viget N, et al. Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl. AIDS. 2009 Sep 24;23(15):1997–2004.

Année 2008

• D’Ortenzio E, Godineau N, Fontanet A, Houze S, Bouchaud O, Matheron S, et al. Prolonged
  Plasmodium falciparum infection in immigrants, Paris. Emerg Infect Dis. 2008 Feb;14(2):323–6.
• Armengaud A, Legros F, D’Ortenzio E, Quatresous I, Barre H, Houze S, et al. A case of autochthonous Plasmodium vivax malaria, Corsica, August 2006. Travel Med Infect Dis. 2008 Mar;6(1–2):36–40.
• Mouala C, Houzé S, Guiguet M, Abboud P, Pialoux G, Viget N, et al. Imported malaria in HIVinfected patients enrolled in the ANRS CO4 FHDH study. J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):55–60.

Année 2007

• Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, et al. Risk factors for imported fatal Plasmodium  falciparum malaria, France, 1996-2003. Emerg Infect Dis. 2007 Jun;13(6):883–8.

Physiopathologie

retour en haut

Année 2020

• Rougeron V, Elguero E, Arnathau C, Acuña Hidalgo B, Durand P, Houze S, et al. Human Plasmodium vivax diversity, population structure and evolutionary origin. PLoS Negl Trop Dis. 2020;14(3):e0008072.

Année 2017

• Argy N, Bertin GI, Milet J, Hubert V, Clain J, Cojean S, et al. Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in France. Clin Microbiol Infect. 2017  Mar;23(3):211.e1-211.e4.
• Argy N, Kendjo E, Augé-Courtoi C, Cojean S, Clain J, Houzé P, et al. Influence of host factors and parasite biomass on the severity of imported Plasmodium falciparum malaria. PLoS One. 2017;12(4):e0175328.

Année 2016

• Javelle E, Madamet M, Gaillard T, Velut G, Surcouf C, Michel R, et al. Delayed Onset of Plasmodium falciparum Malaria after Doxycycline Prophylaxis in a Soldier Returning from the Central African Republic. Antimicrob Agents Chemother. 2016  Apr;60(4):2592–3.
• Bruneel F, Tubach F, Mira J-P, Houze S, Gibot S, Huisse M-G, et al. Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study. Intensive Care Med. 2016 Oct;42(10):1588–96.

Année 2015

• Ndour PA, Lopera-Mesa TM, Diakité SAS, Chiang S, Mouri O, Roussel C, et al. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria. J Infect Dis. 2015 Jan 15;211(2):290–7.
• Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C,  Sonneville R, et al. Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013. Emerg Infect Dis. 2015 May;21(5):804–12.

Résistance

retour en haut

Année 2020

• Massamba L, Madamet M, Benoit N, Chevalier A, Fonta I, Mondain V, et al. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo. Malar J. 2020 Jan 21;19(1):37.
• Mathieu LC, Cox H, Early AM, Mok S, Lazrek Y, Paquet J-C, et al. Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance. Elife. 2020 May 12;9.
• Gendrot M, Madamet M, Mosnier J, Fonta I, Amalvict R, Benoit N, et al. Baseline and multinormal distribution of ex vivo susceptibilities of Plasmodium falciparum to methylene blue in Africa, 2013-18. J Antimicrob Chemother. 2020 Aug 1;75(8):2141–8.
• Foguim FT, Bogreau H, Gendrot M, Mosnier J, Fonta I, Benoit N, et al. Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with
  ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates. Malar J. 2020 Jun 5;19(1):201.

Année 2019

• Foguim FT, Robert MG, Gueye MW, Gendrot M, Diawara S, Mosnier J, et al. Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs. Malar J. 2019 Aug 28;18(1):293.
• Musset L, Heugas C, Naldjinan R, Blanchet D, Houze P, Abboud P, et al. Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana. Antimicrob Agents Chemother. 2019;63(11).

Année 2018

• Gendrot M, Foguim FT, Robert MG, Amalvict R, Mosnier J, Benoit N, et al. The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates. Malar J. 2018 Mar 12;17(1):108.
• Robert MG, Foguim Tsombeng F, Gendrot M, Mosnier J, Amalvict R, Benoit N, et al. Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa. Antimicrob Agents Chemother. 2018;62(11)

Année 2017

• Aurégan C, Argy N, Hubert V, Aprahamian A, Clain J, Cheron G. [Acquisition of atovaquoneproguanil resistance in imported falciparum malaria in a young child]. Presse Med. 2017 Mar;46(3):344–6.

Année 2016

• Madamet M, Briolant S, Amalvict R, Benoit N, Bouchiba H, Cren J, et al. The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine. Parasit Vectors. 2016 Feb 9;9:77.

Année 2015

• Mura M, Briolant S, Donato D, Volney B, Pelleau S, Musset L, et al. Absence of correlation between ex vivo susceptibility to doxycycline and pfteQ-pfmdt gene polymorphism in French Guiana. Malar J. 2015 Jul 25;14:286.
• Pelleau S, Moss EL, Dhingra SK, Volney B, Casteras J, Gabryszewski SJ, et al. Adaptive evolution of malaria parasites in French Guiana: Reversal of chloroquine resistance by acquisition of a mutation in pfcrt. Proc Natl Acad Sci U S A. 2015 Sep 15;112(37):11672–7.
• Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, et al. PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria. Malar J. 2013 Nov 14;12:414.
• Torrentino-Madamet M, Collet L, Lepère JF, Benoit N, Amalvict R, Ménard D, et al. K13- Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014. Antimicrob Agents Chemother. 2015 Dec;59(12):7878–81.

Année 2014

• Cottrell G, Musset L, Hubert V, Le Bras J, Clain J, Atovaquone-Proguanil Treatment Failure Study Group. Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports. Antimicrob Agents Chemother. 2014 Aug;58(8):4504–14.

Année 2013

• Gharbi M, Flegg JA, Pradines B, Berenger A, Ndiaye M, Djimdé AA, et al. Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries. PLoS One. 2013;8(10):e77775.
• Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, et al. PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria. Malar J. 2013 Nov 14;12:414.
• Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, et al. Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Malar J. 2013 Jan 25;12:35.

Année 2012

• Legrand E, Yrinesi J, Ekala M-T, Péneau J, Volney B, Berger F, et al. Discordant temporal evolution of Pfcrt and Pfmdr1 genotypes and Plasmodium falciparum in vitro drug susceptibility to 4-aminoquinolines after drug policy change in French Guiana. Antimicrob Agents Chemother. 2012 Mar;56(3):1382–9.
• Gharbi M, Pillai DR, Lau R, Hubert V, Khairnar K, Existe A, et al. Chloroquine-resistant malaria in travelers returning from Haiti after 2010 earthquake. Emerg Infect Dis. 2012 Aug;18(8):1346–9.

Année 2008

• Kaddouri H, Djimdé A, Dama S, Kodio A, Tekete M, Hubert V, et al. Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali. Int J Parasitol. 2008 Jun;38(7):791–8.
• Durand R, Prendki V, Cailhol J, Hubert V, Ralaimazava P, Massias L, et al. Plasmodium falciparum malaria and atovaquone-proguanil treatment failure. Emerg Infect Dis. 2008 Feb;14(2):320–2.

Année 2007

• Maïga O, Djimdé AA, Hubert V, Renard E, Aubouy A, Kironde F, et al. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis. 2007 Jul 1;196(1):165–72.